These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34748314)

  • 1. Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics.
    Llop J; Lammers T
    ACS Nano; 2021 Nov; 15(11):16974-16981. PubMed ID: 34748314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New liposome-radionuclide-chelate combination for tumor targeting and rapid healthy tissue clearance.
    Umeda IO; Koike Y; Ogata M; Kaneko E; Hamamichi S; Uehara T; Moribe K; Arano Y; Takahashi T; Fujii H
    J Control Release; 2023 Sep; 361():847-855. PubMed ID: 37543291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide-based theranostics - a promising strategy for lung cancer.
    Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled Nanocarriers as Theranostics-Advancement from Peptides to Nanocarriers.
    Desai P; Rimal R; Sahnoun SEM; Mottaghy FM; Möller M; Morgenroth A; Singh S
    Small; 2022 Jun; 18(25):e2200673. PubMed ID: 35527333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating Research for the Radiotheranostics of Nanotargeted
    Chang CH; Chang MC; Chang YJ; Chen LC; Lee TW; Ting G
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Liposomes in Interventional Theranostics of Solid Tumors.
    Kommineni N; Chaudhari R; Conde J; Tamburaci S; Cecen B; Chandra P; Prasad R
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4527-4557. PubMed ID: 37450683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold nanoparticles meet medical radionuclides.
    Daems N; Michiels C; Lucas S; Baatout S; Aerts A
    Nucl Med Biol; 2021; 100-101():61-90. PubMed ID: 34237502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming Nuclear Medicine with Nanoradiopharmaceuticals.
    Roy I; Krishnan S; Kabashin AV; Zavestovskaya IN; Prasad PN
    ACS Nano; 2022 Apr; 16(4):5036-5061. PubMed ID: 35294165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Strategy that Achieves Ultrahigh Contrast by Utilizing Differential Esterase Activity in Organs: Application in Early Detection of Pancreatic Cancer.
    Lee W; Il An G; Park H; Sarkar S; Ha YS; Huynh PT; Bhise A; Bhatt N; Ahn H; Pandya DN; Kim JY; Kim S; Jun E; Kim SC; Lee KC; Yoo J
    ACS Nano; 2021 Nov; 15(11):17348-17360. PubMed ID: 34405675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic nanoparticles.
    Chen F; Ehlerding EB; Cai W
    J Nucl Med; 2014 Dec; 55(12):1919-22. PubMed ID: 25413134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
    Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
    PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
    Emfietzoglou D; Kostarelos K; Sgouros G
    J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
    Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
    Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
    Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
    Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma.
    Filippi L; Frantellizzi V; De Vincentis G
    Cancer Treat Res Commun; 2021; 29():100478. PubMed ID: 34689017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting nanoparticles to malignant tumors.
    Sharma N; Bietar K; Stochaj U
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188703. PubMed ID: 35227830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of
    Petriev VM; Tischenko VK; Mikhailovskaya AA; Popov AA; Tselikov G; Zelepukin I; Deyev SM; Kaprin AD; Ivanov S; Timoshenko VY; Prasad PN; Zavestovskaya IN; Kabashin AV
    Sci Rep; 2019 Feb; 9(1):2017. PubMed ID: 30765778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumor theranostics.
    Ichikawa Y; Kobayashi N; Takano S; Kato I; Endo K; Inoue T
    Cancer Sci; 2022 Jun; 113(6):1930-1938. PubMed ID: 35271754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radionuclide cancer therapy.
    Hoefnagel CA
    Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.